Oct 28HHS draft policy lets licensed pharmacies compound six peptides, including BPC-157. What changed and what did not.
Skip to content
PeptideAgent

Telehealth providers in Florida

By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed.  Last verified

Telehealth prescribing is allowed in Florida, including asynchronous care. What Florida requires of telehealth prescribers and pharmacies, plus listings with their verification status.

Florida at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async allowed
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Telehealth providers serving Florida

Bodybuilding Peptides

Sponsored

Prescription peptides through an online assessment and a licensed provider review, shipped from a licensed U.S. compounding pharmacy.

Telehealth provider · 17 products · partner lists from $172 a month · Says it serves Florida (not yet confirmed)

  • Prescription only, no research-use-only sales
  • Public cancellation and refund policy

We may earn a commission from these links.

Telehealth prescribing rules in Florida

Section 456.47, Florida Statutes, defines telehealth as the use of synchronous or asynchronous telecommunications technology by a telehealth provider to provide health care services, including assessment, diagnosis, consultation, treatment, and monitoring of a patient; e-mail messages and fax transmissions do not count. A telehealth provider may use telehealth to perform a patient evaluation, and if the evaluation is sufficient to diagnose and treat the patient the provider need not conduct a physical examination first, as long as the care meets the prevailing professional standard of practice for in-person care. The statute bars telehealth prescribing of Schedule II controlled substances except for narrow cases (psychiatric disorders, hospital inpatients, hospice, nursing home residents); peptides in this database are not scheduled, so GLP-1 and compounded peptide prescriptions are not affected by that limit. Practitioners licensed in another state must hold a Florida out-of-state telehealth provider registration with the applicable Florida board (or the Department of Health where there is no board) before treating Florida patients, and they cannot open a Florida office or provide in-person care under that registration. A practitioner licensed under a multistate health care licensure compact of which Florida is a member also counts as a telehealth provider. The statute does not mention online questionnaires, and the Board of Medicine's former telemedicine rule 64B8-9.0141 was repealed effective October 14, 2019. This record classifies asynchronous prescribing as allowed because the statute defines telehealth to include asynchronous technology and expressly lets a provider use telehealth to perform the patient evaluation. [2] [3] [4]

Compounded GLP-1 access in Florida

Compounded semaglutide and tirzepatide are limited to the federal exception for documented patient specific needs because the FDA shortage allowances ended in 2025. Florida patients using telehealth GLP-1 programs should confirm the dispensing pharmacy appears in the Department of Health license lookup as a Florida pharmacy or a registered nonresident pharmacy with a sterile compounding permit. [1] [7] [13]

Research use only sellers in Florida

The Florida Drug and Cosmetic Act (chapter 499) prohibits manufacturing, distributing, or selling adulterated, misbranded, or unapproved new drugs in the state (section 499.005), and requires a Florida drug wholesale or manufacturer permit for anyone distributing prescription drugs. Sellers of "research use only" peptides shipped to Florida consumers for injection are not permitted under chapter 499 and are also subject to federal enforcement. [10] [11] [14]

How to check a telehealth provider in Florida

  1. Confirm the prescriber is licensed or registered to treat patients located in Florida; the telehealth rules above explain what Florida requires. [2] [3] [4]
  2. Ask which pharmacy will fill the prescription and check it in the Florida Board of Pharmacy (Florida Department of Health) license lookup. [1] [5] [6] [7] [8] [9] [12]
  3. Get the full price in writing first: consult fees, membership fees, and the medication itself.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Florida. [10] [11] [14]

Common questions in Florida

Can I get a GLP-1 prescription in Florida through telehealth without seeing a doctor in person?

Yes. Florida's telehealth law (section 456.47) allows a licensed or Florida-registered telehealth provider to evaluate you, diagnose, and prescribe using synchronous or asynchronous technology, as long as the care meets the standard of practice. Semaglutide and tirzepatide are not controlled substances, so the Schedule II telehealth restriction does not apply. The statute does not mention online questionnaires. [2] [3]

Can an out-of-state telehealth clinic treat me in Florida?

Only if the practitioner holds a Florida license, a license under a multistate health care licensure compact that Florida has joined, or an out-of-state telehealth provider registration issued by the applicable Florida board (or the Department of Health where there is no board). Registered providers may not open a Florida office or provide in-person services, and the Department of Health can discipline them. Look the provider up in the Department of Health license portal before paying. [2] [3]

Is it legal to buy research peptides online and have them shipped to Florida?

No. Chapter 499 bars the sale and distribution of unapproved or misbranded drugs in Florida and requires permits for anyone distributing prescription drugs. "Research use only" peptides sold for injection are unapproved drugs under both Florida and federal law, and they are not dispensed by a pharmacist. [10] [11] [14]

All peptide legal questions for Florida

Sources

  1. [1]Florida Board of Pharmacy (Florida Department of Health)
  2. [2]Florida Statutes section 456.47, Use of telehealth to provide services
  3. [3]Florida Department of Health: telehealth and out-of-state telehealth provider registration
  4. [4]Florida Administrative Code rule 64B8-9.0141, Standards for Telemedicine Practice (repealed October 14, 2019), accessed 2026-09-30
  5. [5]Florida Statutes chapter 465, Pharmacy
  6. [6]Florida Statutes section 465.0156, Registration of nonresident pharmacies
  7. [7]Florida Statutes section 465.0158, Nonresident sterile compounding permit
  8. [8]Florida Administrative Code rule 64B16-27.700, Definition of compounding
  9. [9]Florida Administrative Code rule 64B16-27.797, Standards of practice for compounding sterile preparations
  10. [10]Florida Statutes chapter 499, Florida Drug and Cosmetic Act